You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer
|
---|---|
Published in |
European Journal of Surgical Oncology, September 2005
|
DOI | 10.1016/j.ejso.2005.04.014 |
Pubmed ID | |
Authors |
G.P.H. Gui, D.J. Joubert, R. Reichert, A. Ward, S. Lakhani, P. Osin, A. Nerurkar, R. A'Hern, K. Benson, S.R. Underwood |
Abstract |
Sentinel lymph node biopsy (SLNB) has become increasingly accepted as a diagnostic method to stage the axilla in breast cancer, selecting women with a positive sentinel node for completion axillary clearance. As SLNB became established, many surgeons supplemented SLNB to sample a minimum of four lymph nodes, on the assumption that the four-node technique is supported by randomised trial data. We hypothesised that the practice of undirected sampling to supplement SLNB adds little information to the status of the residual axilla. |
Mendeley readers
The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 6% |
United Kingdom | 1 | 6% |
Denmark | 1 | 6% |
Unknown | 14 | 82% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 24% |
Professor | 2 | 12% |
Student > Bachelor | 2 | 12% |
Other | 2 | 12% |
Student > Ph. D. Student | 2 | 12% |
Other | 5 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 53% |
Social Sciences | 2 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Economics, Econometrics and Finance | 1 | 6% |
Agricultural and Biological Sciences | 1 | 6% |
Other | 2 | 12% |
Unknown | 1 | 6% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2012.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from European Journal of Surgical Oncology
#616
of 2,688 outputs
Outputs of similar age
#13,088
of 69,132 outputs
Outputs of similar age from European Journal of Surgical Oncology
#1
of 11 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,688 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,132 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.